Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:50AM ET
5.87
Dollar change
+0.22
Percentage change
3.89
%
IndexRUT P/E- EPS (ttm)-1.46 Insider Own40.33% Shs Outstand42.41M Perf Week16.24%
Market Cap249.01M Forward P/E- EPS next Y-0.75 Insider Trans12.66% Shs Float25.31M Perf Month2.62%
Income-67.00M PEG- EPS next Q-0.45 Inst Own42.46% Short Float17.37% Perf Quarter-17.90%
Sales5.12M P/S48.63 EPS this Y-2.53% Inst Trans-9.35% Short Ratio26.96 Perf Half Y53.66%
Book/sh0.47 P/B12.60 EPS next Y50.82% ROA-106.07% Short Interest4.40M Perf Year-9.27%
Cash/sh1.64 P/C3.58 EPS next 5Y- ROE-224.08% 52W Range2.86 - 7.76 Perf YTD-19.81%
Dividend Est.- P/FCF- EPS past 5Y-0.97% ROI-103.75% 52W High-24.31% Beta1.87
Dividend TTM- Quick Ratio4.49 Sales past 5Y-13.60% Gross Margin75.34% 52W Low105.24% ATR (14)0.35
Dividend Ex-Date- Current Ratio4.55 EPS Y/Y TTM-78.42% Oper. Margin-1233.82% RSI (14)64.55 Volatility7.58% 6.83%
Employees100 Debt/Eq2.30 Sales Y/Y TTM-43.27% Profit Margin-1307.47% Recom1.00 Target Price13.67
Option/ShortYes / Yes LT Debt/Eq2.27 EPS Q/Q-268.07% Payout- Rel Volume0.34 Prev Close5.65
Sales Surprise103.86% EPS Surprise5.69% Sales Q/Q2823.53% EarningsFeb 29 BMO Avg Volume163.08K Price5.87
SMA2014.92% SMA509.46% SMA20018.25% Trades Volume21,956 Change3.89%
Date Action Analyst Rating Change Price Target Change
Jul-25-23Upgrade Needham Hold → Buy $10
Mar-22-23Initiated Jefferies Buy $10
Feb-13-23Upgrade RBC Capital Mkts Sector Perform → Outperform $4 → $11
May-25-22Downgrade RBC Capital Mkts Outperform → Sector Perform $16 → $4
May-14-21Initiated RBC Capital Mkts Outperform $19
Dec-24-20Reiterated H.C. Wainwright Buy $18 → $21
Jul-15-20Downgrade BofA Securities Buy → Neutral
Jun-30-20Reiterated H.C. Wainwright Buy $24 → $18
Jun-24-20Initiated Northland Capital Outperform $21
Mar-24-20Initiated Needham Buy $20
Mar-26-24 07:30AM
Mar-01-24 09:10AM
Feb-29-24 08:11AM
07:30AM
Feb-27-24 07:30AM
07:30AM Loading…
Feb-22-24 07:30AM
Feb-05-24 07:30AM
Jan-29-24 07:30AM
Jan-22-24 07:44PM
Jan-05-24 07:30AM
Jan-04-24 07:30AM
Jan-03-24 07:30AM
Dec-15-23 01:49PM
06:00AM
Nov-11-23 10:13AM
08:00AM Loading…
Nov-10-23 08:00AM
Nov-09-23 07:30AM
Oct-25-23 07:00AM
Sep-27-23 08:00AM
Aug-31-23 08:00AM
Aug-24-23 08:30AM
Aug-23-23 07:30AM
Aug-10-23 04:05PM
Aug-08-23 07:30AM
Aug-03-23 07:30AM
Jul-27-23 06:06AM
Jul-26-23 04:05PM
Jul-25-23 07:16AM
Jul-24-23 03:16PM
07:00AM
04:47PM Loading…
Jul-21-23 04:47PM
04:30PM
04:24PM
Jul-17-23 07:22AM
Jul-12-23 03:16AM
May-31-23 07:00AM
May-30-23 12:34PM
May-10-23 07:30AM
06:11AM
May-09-23 07:30AM
May-05-23 09:07AM
Apr-26-23 08:01PM
Apr-12-23 07:00AM
Apr-11-23 07:00AM
Mar-06-23 07:30AM
Feb-28-23 04:05PM
Feb-27-23 04:05PM
Feb-22-23 11:49AM
Feb-21-23 07:22AM
Feb-17-23 06:43PM
Feb-14-23 10:15AM
Jan-24-23 07:30AM
07:16AM
Jan-04-23 07:30AM
Jan-01-23 08:16AM
Dec-12-22 12:07PM
Nov-26-22 07:00AM
Nov-07-22 04:05PM
Aug-31-22 04:30PM
Aug-17-22 07:53AM
Aug-11-22 07:30AM
Aug-04-22 01:38PM
12:34PM
Aug-03-22 12:02PM
Aug-01-22 07:30AM
Jul-20-22 12:00PM
Jul-18-22 11:43AM
Jul-07-22 06:10AM
Jul-06-22 09:31AM
Jul-01-22 09:36AM
Jun-29-22 09:23PM
04:01PM
03:26PM
Jun-28-22 07:30AM
Jun-17-22 09:35AM
Jun-13-22 09:55AM
Jun-05-22 08:42AM
Jun-01-22 09:35AM
May-26-22 03:37PM
May-25-22 03:14PM
08:18AM
06:39AM
May-24-22 09:12PM
08:00PM
May-17-22 11:53AM
May-16-22 09:35AM
May-13-22 09:35AM
May-11-22 06:35AM
May-09-22 07:30AM
Apr-08-22 12:15PM
Apr-07-22 07:30AM
Apr-05-22 07:30AM
Mar-06-22 06:45AM
Mar-02-22 04:05PM
Feb-24-22 07:30AM
Dec-17-21 05:23AM
Dec-15-21 04:05PM
Dec-08-21 05:01AM
Nov-29-21 07:30AM
Nov-22-21 11:22AM
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerDec 29 '23Buy7.24115,774838,2047,099,182Dec 29 05:27 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 28 '23Buy7.08126,116892,9016,983,408Dec 29 05:27 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 27 '23Buy7.2079,726574,0276,857,292Dec 29 05:27 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 26 '23Buy6.4954,652354,6916,777,566Dec 26 07:21 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 22 '23Buy6.67250,0001,667,5006,722,914Dec 26 07:21 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 21 '23Buy6.17200,0001,234,0006,472,914Dec 26 07:21 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 19 '23Buy5.36277,0081,484,7636,272,914Dec 19 05:52 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 18 '23Buy5.41456,9232,471,9535,995,906Dec 19 05:52 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 15 '23Buy5.97500,0002,985,0005,538,983Dec 19 05:52 PM
Hayes Christopher G.Chief Legal OfficerNov 15 '23Sale2.9711,55834,327123,226Nov 16 04:32 PM
White TedPresident and CEONov 15 '23Sale2.9711,55834,327170,090Nov 16 04:33 PM
Bonaccorso JoeChief Commercial OfficerNov 15 '23Sale2.9711,26633,46092,392Nov 16 04:49 PM
Kohler TerryChief Financial OfficerNov 15 '23Sale2.979,63228,60734,416Nov 16 04:34 PM
Goldenberg GaryChief Medical OfficerNov 15 '23Sale2.973,0369,01786,257Nov 16 04:35 PM
Hayes Christopher G.Chief Legal OfficerNov 14 '23Sale2.9322,14164,873134,784Nov 16 04:32 PM
White TedPresident and CEONov 14 '23Sale2.9322,14164,873181,648Nov 16 04:33 PM
Bonaccorso JoeChief Commercial OfficerNov 14 '23Sale2.9321,58063,229103,658Nov 16 04:49 PM
Kohler TerryChief Financial OfficerNov 14 '23Sale2.9318,45254,06444,048Nov 16 04:34 PM
Goldenberg GaryChief Medical OfficerNov 14 '23Sale2.935,81717,04489,293Nov 16 04:35 PM
Manning Paul BDirectorJul 24 '23Buy5.02200,0001,004,0007,851,128Jul 24 06:47 PM
White TedPresident and CEOJul 24 '23Sale4.8350,677244,770128,789Jul 25 04:18 PM
Bonaccorso JoeChief Commercial OfficerJul 24 '23Sale4.8338,262184,80562,738Jul 25 04:22 PM
Hayes Christopher G.Chief Legal OfficerJul 24 '23Sale4.8333,789163,20181,925Jul 25 04:25 PM
Goldenberg GaryChief Medical OfficerJul 24 '23Sale4.8328,699138,61670,110Jul 25 04:23 PM